Neuropace Inc (NPCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,465 | -27,141 | -32,956 | -47,082 | -36,080 |
| Depreciation Amortization | 2,185 | 1,997 | 455 | 525 | 563 |
| Accounts receivable | -1,830 | -536 | -4,850 | -391 | 1,304 |
| Accounts payable and accrued liabilities | -730 | 671 | 240 | 647 | 479 |
| Other Working Capital | -4,012 | -5,452 | -1,051 | -2,068 | 368 |
| Other Operating Activity | 14,846 | 12,512 | 18,461 | 11,500 | 8,789 |
| Operating Cash Flow | $-11,006 | $-17,949 | $-19,701 | $-36,869 | $-24,577 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 9,300 | 23,200 | 24,400 | -85,012 |
| PPE Investments | -332 | -306 | -173 | -603 | -384 |
| Investing Cash Flow | $-332 | $8,994 | $23,027 | $23,797 | $-85,396 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 58,435 | N/A | N/A | N/A | N/A |
| Debt Repayment | -60,507 | N/A | N/A | N/A | -4,090 |
| Common Stock Issued | 71,761 | 5,208 | 8,691 | 896 | 110,008 |
| Common Stock Repurchased | -49,546 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -543 | -881 | -564 | -406 | -3,392 |
| Financing Cash Flow | $19,600 | $4,327 | $8,127 | $490 | $102,526 |
| Beginning Cash Position | 13,552 | 18,180 | 6,727 | 19,309 | 26,756 |
| End Cash Position | 21,814 | 13,552 | 18,180 | 6,727 | 19,309 |
| Net Cash Flow | $8,262 | $-4,628 | $11,453 | $-12,582 | $-7,447 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,006 | -17,949 | -19,701 | -36,869 | -24,577 |
| Capital Expenditure | -332 | -306 | -173 | -603 | -384 |
| Free Cash Flow | -11,338 | -18,255 | -19,874 | -37,472 | -24,961 |